DEMECAN
PrivateLast Round
VC Round
Aug 7, 2024
Est. Valuation
$109.2M
Total Funding Raised
$7.63M
Company Overview
DEMECAN operates in Healthcare & Life Sciences and is based in Ebersbach. Its latest recorded funding round was a VC Round in August 2024.
DEMECAN is a pharmaceuticals and biotechnology company that produces, imports, and supplies medical cannabis in Germany.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Pharma Supply Chain, Supply Chain
Business Model
B2B
Customer Profile
Government Contracts, Services & Consulting, Data as a Service
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
DEMECAN Comparables
Compare DEMECAN with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Semdor Pharma Group | 84% | |
| SOMAÍ Pharmaceuticals | 83% | |
| enua Pharma GmbH | 83% |
For institutional investors. Book with your work email.
DEMECAN Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Aug 7, 2024 | ||||
| VC Round | Dec 19, 2022 | ||||
| VC Round | Apr 15, 2021 | ||||
| Series A Extension | May 19, 2020 | ||||
| Series A | Oct 1, 2019 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
DEMECAN Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Mittelständische Beteiligungsgesellschaft Sachsen | VC Round |
| Futury Capital | VC Round |
| b2venture | VC Round, Series A |
| Future Capital AG | Series A |
| Trog Hawley Capital | VC Round |
| ENEXIS | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 26, 2026
Expanding cultivation at Ebersbach site to boost domestic production capacity.
- Dec 19, 2022
$16M raised from b2venture, ENEXIS, and others.
For institutional investors. Book with your work email.
DEMECAN Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about DEMECAN's valuation, stock price, and market status.
Is DEMECAN a public or private company?
DEMECAN is a private company.
What is the current stock price of DEMECAN?
DEMECAN is a private company, so its shares have no public market price. Caplight tracks DEMECAN's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is DEMECAN worth (valuation)?
DEMECAN's valuation is estimated at $109.2M based on funding round data.
Can I buy DEMECAN stock?
DEMECAN shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was DEMECAN's last funding round?
DEMECAN's most recent funding round was VC Round on August 7, 2024.
Who are the main investors in DEMECAN?
Key investors in DEMECAN include Futury Capital, b2venture, Trog Hawley Capital.
Will DEMECAN IPO soon?
No public IPO plans have been announced for DEMECAN.
How can I track DEMECAN secondary market activity?
Caplight tracks bids, offers, and trades in DEMECAN's shares on secondary markets.